Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy: a Prospective Multi-centre Observational Study

NCT03843255 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT03843255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03843255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy: a Prospective Multi-centre Observational Study
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Active, not recruiting
Start date
January 9, 2020
Completion date
June 16, 2029
Enrollment
2,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, dilated cardiomyopathy